About
Hong Wang is a Laura H. Carnell Professor and Director at the Center for Metabolic Disease Research, Temple University. He holds academic roles across multiple departments including the Cardiovascular Research Center, Sol Sherry Thrombosis Research Center, and Microbiology, Immunology and Inflammation. His research focuses on metabolic and pathological mechanisms in cardiovascular diseases, with emphasis on hyperlipidemia, diabetes, and vascular inflammation. Key techniques include metabolomics, transcriptomics, and animal models.
- Education:
- EMBA, The Fox School of Business, Temple University (2009)
- Postdoctoral Fellow, Harvard School of Public Health (1997)
- PhD, University of Montreal (1996)
- MSc, Peking Union Medical College (1985)
- MD, Jiang Xi Medical School (1979)
Research Interests: Investigation of metabolic disorders' impact on vascular health, including atherosclerosis, endothelial dysfunction, and epigenetic modifications. Active in developing therapies via gene and stem cell approaches. Collaborates on advanced technologies like RNA-Seq and CHIP-Seq.
Publications: Over 140 articles, with recent trends addressing trained immunity, mitochondrial dysfunction, and immune checkpoint roles in vascular diseases. Highlights include studies on CD155/CD274 pathways and YBX2 anti-ROS mechanisms in kidney disease.
Labs/Teams: Leads the Wang Laboratory and collaborates across Temple’s research centers. Focus areas include metabolic disease research, thrombosis, and translational medicine.
